Senate Bill, 89th Legislature, Regular Session (2025)
SB 1525
Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.
Filed by Sen. Menéndez (D).
How far it got in 2025
Passed the Senate; died in the House
Last official action May 8, 2025.
Who testified
Who signed up to testify at each committee hearing, and where they stood, from the committee's official witness list.
Senate Health & Human Services, April 23, 2025
Official witness list7 for, 2 against, 1 on2 spoke at the hearing; the rest registered a position or sent written testimony. “On” means neither for nor against, often an agency answering questions.
Organizations represented (10)
- Teaching Hospitals of Texasregistered lobby clientfor
- Texas Association of Businessregistered lobby clientagainst
- Texas Association of Health Plansregistered lobby clientagainst
- Texas Chapter American College of Physiciansfor
- Texas Coalition For Patientsregistered lobby clientfor
- Texas Council of Community Centersregistered lobby clientfor
- Texas Department of Insuranceon
- Texas Hospital Associationregistered lobby clientfor
- Texas Medical Associationregistered lobby clientfor
- Texas Women’s Healthcare Coalitionfor
Names appear as printed on the official list. “Registered lobby client” means the organization's name matches a client in 2025 lobby registrations filed with the Texas Ethics Commission; organizations whose names are spelled differently there aren't marked.
We keep a summary of each 2025 bill. Its full history, text, amendments, and votes are on Texas Legislature Online.